Cardinal Health extends CVS deal, trades 6% below target
Alpha Vantage · Simply Wall Street · · AI-summarised by FinFlash
Cardinal Health reaffirmed its multi-year non-GAAP EPS guidance and extended its distribution agreement with CVS Health through 2032. The stock has posted strong short-term and year-to-date gains. Analysts see roughly 6% upside, with a fair value near $270.94 versus a $253.71 price, though the 34.3x P/E sits above peers.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.